Multiple Sclerosis International Federation


website | contact us | donate
{{if listFind(vars.channel_names, "MSIF News")}}
{{endif}}
{{if listFind(vars.channel_names, "MSIF News")}}
{{endif}}
{{if listFind(vars.channel_names, "MSIF News")}}

MSIF News
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}

Profile of the Month
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}

Research News
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}

MS News
{{endif}}
{{if listFind(vars.channel_names, "MSIF News")}}
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
{{endif}}
 

Making Connections

 

Research News

Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London.
n-Dodecyl-beta-D: -Maltoside Inhibits Aggregation of Human Interferon-beta-1b and Reduces Its Immunogenicity

A group from John Hopkins report initial findings of the success of the compound, dodecylmaltoside, a nontoxic alkylsaccharide surfactant, at reduce aggregation of interferon-beta in vitro.

The researchers suggest that by preventing aggregation of interferon-beta, formation of neutralizing antibodies may be prevented. In experiment where mice were given interferon-beta with and without dodecylmaltoside, it was also found to reduce the immunogenicity in vivo. The authors suggest the results warrant additional tests of dodecylmaltoside as a therapeutic adjuvant in rodent models of multiple sclerosis.

authors: Rifkin RA, Maggio ET, Dike S, Kerr DA, Levy M.

source: J Neuroimmune Pharmacol. 2011 Mar;6(1):158-62. Epub 2010 Jun 8.

read more

Tumor necrosis factor alpha gene -376 polymorphism and susceptibility to multiple sclerosis: an Egyptian study

This interesting genetics study from Egypt examines for polymorphism at position 376 in the TNF-alpha gene in patients with MS and controls. The GG genotype was found to be significantly more prevalent in patients with PPMS and RRMS, than in healthy controls.

The results are of significance due to the known pro-inflammatory role of TNF-alpha. The results would suggest a possible increased susceptibility towards MS in subjects with the GG genotype.

authors: Nada MA, Labib DA.

source: J Neuroimmune Pharmacol. 2011 Mar;6(1):142-7. Epub 2010 May 25.

read more

Identification and Clinical Impact of Multiple Sclerosis Cortical Lesions as Assessed by Routine 3T MR Imaging

The authors reviewed cortical lesions in 26 patients with MS using 3D FLAIR and 3D T1-weighted IR-SPGR 3T MR images. The authors were able to identify mixed cortical-subcortical (type I) and purely intracortical (type II) lesions on MR sequences but the technical difficulty of detecting subpial cortical lesions was highlighted once again by this paper.

Cortical lesion number was correlated with the CVLT-II scores. The EDSS scores correlated with cortical lesion number and cortical lesion volume, but not with white matter lesion volume. The paper demonstrates that routinely detectable cortical lesions are related to physical disability and cognitive impairment.

authors: Mike A, Glanz BI, Hildenbrand P, Meier D, Bolden K, Liguori M, Dell'oglio E, Healy BC, Bakshi R, Guttmann CR.

source: AJNR Am J Neuroradiol. 2011 Feb 10. [Epub ahead of print]

read more

   
 

Tell a friend

The email you subscribed with us is {{print email}}

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here. If you have any problems with the direct link, you can log into My World of MS and untick the email subscription details.

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.